Mason et al., 1975 - Google Patents
Reactivity of blood with biomaterials in vitro: evaluation of some in vitro test systems for estimation of the blood compatibility of biomaterialsMason et al., 1975
- Document ID
- 6507484089100423139
- Author
- Mason R
- Shinoda B
- Publication year
- Publication venue
- Biomaterials, Medical Devices, and Artificial Organs
External Links
Snippet
Several different in vitro tests designed to estimate the degree of compatibility of blood with biomaterials have been examined to determine possible effects of donor or donor-material interaction. Statistical evaluation of data was performed, and adequate data were collected …
- 210000004369 Blood 0 title abstract description 91
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4905—Determining clotting time of blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Boyd et al. | Permeability of lung capillaries to macromolecules in foetal and new‐born lambs and sheep | |
| Ruggeri et al. | Immunoradiometric assay of factor VIII related antigen, with observations in 32 patients with von Willebrand's disease | |
| Olson et al. | Evaluation of Ristocetin–Willebrand Factor Assay and Ristocetin-induced Platelet Aggregation | |
| O'brien et al. | Shear stress activation of platelet glycoprotein IIb/IIIa plus von Willebrand factor causes aggregation: filter blockage and the long bleeding time in von Willebrand's disease | |
| US5089422A (en) | Vitro bleeding time determination | |
| Caekebeke‐Peerlinck et al. | Bleeding time, blood groups and von Willebrand factor | |
| Horowitz et al. | Change in platelet factor 3 as a means of demonstrating immune reactions involving platelets: its use as a test for quinidine‐induced thrombocytopenia | |
| Chaplin et al. | Quantitation of red blood cell‐bound C3d in normal subjects and random hospitalized patients | |
| Evans et al. | Assay of ristocetin co‐factor using fixed platelets and a platelet counting technique | |
| Kim et al. | Effect of phthalate plasticizer on blood compatibility of polyvinyl chloride | |
| Alving et al. | In vitro studies of heparin-associated thrombocytopenia | |
| Lindsay | Platelets, foreign surfaces, and heparin | |
| Parzer et al. | Plasma protein adsorption to hemodialysis membranes: studies in an in vitro model | |
| Mason et al. | Reactivity of blood with biomaterials in vitro: evaluation of some in vitro test systems for estimation of the blood compatibility of biomaterials | |
| Bowry et al. | Utilization of the platelet release reaction in the blood compatibility assessment of polymers | |
| Bowry et al. | A modification of the Wu and Hoak method for the determination of platelet aggregates and platelet adhesion | |
| Ur | Detection of clot retraction through changes of the electrical impedance of blood during coagulation | |
| Green et al. | Urinary loss of clotting factors due to hereditary membranous glomerulopathy | |
| Bruck | Evaluation of blood compatibility of polymeric implants | |
| Limber et al. | Studies of the proteins elutable from certain artificial surfaces exposed to human plasma | |
| Jung et al. | Haemocompatibility of Endovascular Coronary Stents: Wiktor GX©. Hämokompatibilität von Koronarstents: Wiktor GX© | |
| Zucker et al. | Experimental interactions of components of hemodialysis units with human blood | |
| Abe et al. | Rheumatoid factor-like substance and antistreptolysin O antibody in leprosy serum | |
| Perkins et al. | Low molecular weight dextran in open heart surgery: Effect on coagulation factors and on red cell antibody activity | |
| Rampling et al. | Fibrinogen, fibrinogen degradation products and erythrocyte flexibility |